Dipeptidyl-peptidase-4 inhibitors have anti-inflammatory effects in patients with type 2 diabetes

被引：0
|
作者：
Dengpiao Xie
Qiqi Wang
Wei Huang
Liangbin Zhao
机构：
[1] Hospital of Chengdu University of Traditional Chinese Medicine,
来源：
European Journal of Clinical Pharmacology | 2023年 / 79卷
关键词：
Dipeptidyl-peptidase-4 inhibitors; Inflammation; Type 2 diabetes mellitus; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1291 / 1301
页数：10
相关论文
共 50 条
  • [31] Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes
    Scheen, Andre J.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (04) : 505 - 524
  • [32] Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
    Jang, Yun-Mi
    Kim, Dong-Lim
    DIABETES & METABOLISM JOURNAL, 2011, 35 (02) : 117 - 118
  • [33] Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
    Geng, Jinsong
    Yu, Hao
    Mao, Yiwei
    Zhang, Peng
    Chen, Yingyao
    PHARMACOECONOMICS, 2015, 33 (06) : 581 - 597
  • [34] Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
    Mkele, Gail
    SOUTH AFRICAN FAMILY PRACTICE, 2013, 55 (06) : 508 - 510
  • [35] Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus
    Neumiller, Joshua J.
    Wood, Lindy
    Campbell, R. Keith
    PHARMACOTHERAPY, 2010, 30 (05): : 463 - 484
  • [36] Pharmacogenetics of dipeptidyl peptidase 4 inhibitors in a Taiwanese population with type 2 diabetes
    Liao, Wen-Ling
    Lee, Wen-Jane
    Chen, Ching-Chu
    Lu, Chieh Hsiang
    Chen, Chien-Hsiun
    Chou, Chun
    Lee, I-Te
    Sheu, Wayne H-H
    Wu, Jer-Yuarn
    Yang, Chi-Fan
    Wang, Chung-Hsing
    Tsai, Fuu-Jen
    ONCOTARGET, 2017, 8 (11) : 18050 - 18058
  • [37] Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
    Mkele, Gail
    SA PHARMACEUTICAL JOURNAL, 2013, 80 (02) : 17 - 19
  • [38] Efficacy of -glucosidase inhibitors combined with dipeptidyl-peptidase-4 inhibitor (alogliptin) for glucose fluctuation in patients with type2 diabetes mellitus by continuous glucose monitoring
    Kurozumi, Akira
    Okada, Yosuke
    Mori, Hiroko
    Arao, Tadashi
    Tanaka, Yoshiya
    JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (04) : 393 - 398
  • [39] Concordance with prescribing information dosage recommendations for dipeptidyl-peptidase-4 inhibitors among type 2 diabetes mellitus patients with moderate to severe chronic kidney disease
    Huang, Huan
    Shetty, Sharash
    Bauer, Elise
    Lang, Kathleen
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (06) : 1021 - 1027
  • [40] The Effects of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Disease Risks in Type 2 Diabetes Mellitus
    Yousefzadeh, Pegah
    Wang, Xiangbing
    JOURNAL OF DIABETES RESEARCH, 2013, 2013
12345